Risperdal M-tab Tablet, Orally Disintegrating
Product Images NDC 50458-325
Product Visual Gallery
This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Risperdal M-tab (NDC 50458-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Risperdal 02)
Step 1 (Risperdal 03)
Step 2 (Risperdal 04)
Step 3 (Risperdal 05)
Step 4 (Risperdal 05a)
Step 5 (Risperdal 05b)
Figure 6a (Risperdal 05c)
Figure 6b (Risperdal 05d)
Step 7 (Risperdal 05e)
Step 8 (Risperdal 05f)
Figura (Risperdal 05g)
Paso 1 (Risperdal 05h)
Paso 2 (Risperdal 05i)
Paso 3 (Risperdal 05j)
Paso 4 (Risperdal 05k)
Paso 5 (Risperdal 05l)
Figura 6a (Risperdal 05m)
Figura 6b (Risperdal 05n)
Paso 7 (Risperdal 05o)
Paso 8 (Risperdal 05p)
Principal Display Panel (0.5 mg Bottle Label)
Principal Display Panel (1 mg Bottle Label)
Principal Display Panel (2 mg Bottle Label)
Principal Display Panel (3 mg Bottle Label)
Principal Display Panel (4 mg Bottle Label)
Principal Display Panel (0.5 mg Tablet Carton)
Principal Display Panel (1 mg Tablet Carton)
Principal Display Panel (2 mg Tablet Carton)
Principal Display Panel (3 mg Tablet Carton)
Principal Display Panel (4 mg Tablet Carton)
Risperdal Os 1mg (Risperdal Os 1mg Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.